Scarica l'app Stockscreener
7.74
1.44%
0.11
Pre-mercato:
7.75
0.010
+0.13%
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
XTX Topco Ltd Takes $145,000 Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Signal strength of Lifecore Biomedical Inc. stock in tech scannersJuly 2025 Fed Impact & Precise Buy Zone Tips - Newser
Technical analysis overview for Lifecore Biomedical Inc. stock2025 Growth vs Value & AI Enhanced Trading Signals - Newser
Should you hold or exit Lifecore Biomedical Inc. nowMulti-Bagger Detection with Trend Tools - Newser
Is Lifecore Biomedical Inc. stock a good hedge against inflation2025 Price Momentum & Breakout Confirmation Alerts - Newser
Volume spikes in Lifecore Biomedical Inc. stock – what they meanWeekly Growth Portfolio Performance Summary - Newser
What to expect from Lifecore Biomedical Inc. in the next 30 daysFree Entry Alert With Low Drawdown Strategy - Newser
Short interest data insights for Lifecore Biomedical Inc.Quarterly Investment Outlook and Key Summary - Newser
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Lifecore Biomedical Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Using Ichimoku Cloud for Lifecore Biomedical Inc. technicalsTechnical Insight Guide for Safer Trades - Newser
Custom strategy builders for tracking Lifecore Biomedical Inc.Daily Market Movers Screener with Filters - Newser
Lifecore Biomedical Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingPredictable Return Strategy with AI Support - Newser
Lifecore Biomedical Exceeds Revenue Estimates, Reports Q4 $36.4M and EPS Loss of $0.06 - AInvest
Lifecore Biomedical Inc. Attempts Reversal From Key SupportAI Forecast for Trending Stocks Indicates Upside - beatles.ru
Lifecore Biomedical 2025 Q4 Earnings Significant Net Loss Improvement - AInvest
Lifecore (LFCR) Q4 Revenue Beats 3% - AOL.com
Lifecore Biomedical shares fall 3.61% intraday despite reporting $128.9 million in fiscal 2025 revenue. - AInvest
Lifecore Biomedical: Navigating Headwinds with Strategic Resilience and Long-Term Growth Catalysts - AInvest
Lifecore Biomedical's Q4 2025: Unpacking Key Contradictions on Tariffs, Demand, and Market Growth - AInvest
The one-year returns have been decent for Lifecore Biomedical (NASDAQ:LFCR) shareholders despite underlying losses increasing - simplywall.st
Earnings call transcript: Lifecore Biomedical Q4 2025 sees stock rise despite EPS miss - Investing.com Nigeria
Earnings call transcript: Lifecore Biomedical Q4 2025 sees stock rise despite EPS miss By Investing.com - Investing.com South Africa
Lifecore Biomedical: Fiscal Q4 Earnings Snapshot - Connecticut Post
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Lifecore Biomedical Inc reports results for the quarter ended May 31Earnings Summary - TradingView
Transcript : Lifecore Biomedical, Inc., Q4 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates - sharewise.com
Lifecore Biomedical’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating - TipRanks
Lifecore Biomedical earnings missed by $0.02, revenue topped estimates - Investing.com South Africa
Lifecore Biomedical reports $128.9mln FY25 revenue, meets full-year guidance. - AInvest
Lifecore Biomedical Reports Q4 and FY25 Financial Results, Achieves Full-Year Guidance, and Provides Corporate Update - AInvest
Laughing Water Capital's Top 5 Holdings for Q2 2025 - AInvest
Laughing Water Capital's Top 5 Positions For Q2 2025 - Seeking Alpha
Lifecore Biomedical Reports 2025 Financial Results - TipRanks
Momentum divergence signals in Lifecore Biomedical Inc. chartFree Early Entry Tips With Low Risk Zone - Newser
How hedge fund analytics apply to Lifecore Biomedical Inc. stockBreakout Monitoring with Momentum Analysis - Newser
Ranking Lifecore Biomedical Inc. among high performing stocks via toolsPortfolio Review Summary with Five-Year Outlook - Newser
Can Lifecore Biomedical Inc. stock recover from recent declineDay Trading Setup Forecast with Trend Model - Newser
Lifecore Biomedical Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
What drives Lifecore Biomedical Inc. stock priceBuild a diversified portfolio for stability - Jammu Links News
What catalysts could drive Lifecore Biomedical Inc. stock higher in 2025Rapid return acceleration - Jammu Links News
What institutional investors are buying Lifecore Biomedical Inc. stockInvest confidently with professional market insights - Jammu Links News
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):